ENTA

Enanta Pharmaceuticals Inc

Jun 02 • 04:00PM ET

12.03

-0.64 -5.05 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NKTR KROS INCY VKTX BMRN KRYS RYTM AXSM MDGL NBIX

| Held by: VTI IWM VXF IWN IBB VTWO SCHA DWAS VFMO IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.59	Insider Own	5.09%	Shs Outstand	29.06M	Perf Week	-11.09%
Market Cap	349.81M	Forward P/E	-	EPS next Y	-1.75	Insider Trans	-0.86%	Shs Float	27.60M	Perf Month	-16.17%
Enterprise Value	372.66M	PEG	-	EPS next Q	-0.45	Inst Own	92.28%	Short Float	7.98%	Perf Quarter	-18.27%
Income	-61.98M	P/S	5.05	EPS this Y	40.73%	Inst Trans	0.15%	Short Ratio	13.02	Perf Half Y	-14.80%
Sales	69.21M	P/B	3.00	EPS next Y	22.96%	ROA	-19.44%	Short Interest	2.20M	Perf YTD	-23.72%
Book/sh	4.01	P/C	2.14	EPS next 5Y	17.16%	ROE	-59.00%	52W High	17.15 -29.85%	Perf Year	91.26%
Cash/sh	5.63	P/FCF	-	EPS past 3/5Y	13.40% -16.17%	ROIC	-23.13%	52W Low	5.88 104.59%	Perf 3Y	-53.61%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.82% -11.81%	Gross Margin	92.87%	Volatility	4.73% 5.67%	Perf 5Y	-73.94%
Dividend TTM	-	EV/Sales	5.38	EPS Y/Y TTM	42.85%	Oper. Margin	-87.24%	ATR (14)	0.72	Perf 10Y	-53.67%
Dividend Ex-Date	-	Quick Ratio	3.84	Sales Y/Y TTM	7.37%	Profit Margin	-89.56%	RSI (14)	29.97	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	3.84	EPS Q/Q	57.49%	SMA20	-13.39%	Beta	0.99	Target Price	20.62
Payout	-	Debt/Eq	1.60	Sales Q/Q	14.96%	SMA50	-11.73%	Rel Volume	1.17	Prev Close	12.67
Employees	120	LT Debt/Eq	1.30	Earnings	May 11 AMC	SMA200	-3.82%	Avg Volume	169.16K	Price	12.03
IPO	Mar 21, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.65% 0.77%	Trades		Volume	196,987	Change	-5.05%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)